ORTEXORTEX News
Tracking RPM? Get live short interest, options flow, and signals on ORTEX.Sign up free →
RP
Earnings PreviewRPM

RPM Options Traders Turn Cautious as Earnings Loom

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 29 Sept 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of RPM International Inc. (RPM) share price and short interest (% of free float), three months to September 25, 2026
ORTEX data as of 29 Sept 2026, 04:00

RPM International reports on October 2 against a backdrop where options hedging has spiked sharply while the bullish analyst consensus from the prior article remains intact — but Morgan Stanley moved to trim its target further just yesterday.

The clearest shift heading into the print is in options markets. Put demand has jumped to its most elevated level in months relative to recent norms: the put/call ratio hit 0.22 on Monday, almost three standard deviations above its 20-day average of 0.16. That's not an extreme absolute reading, but the z-score of nearly 3.0 marks the sharpest defensive lean in recent history for this name. The stock has given back a further point since the previous article, now trading at $100.20 — down 6% over the past month and testing the $100 psychological level just days before the print.

The divergence from peers is notable. On Monday alone, SHW gained 2.7%, PPG rose 1.1%, and ECL added 1.5%. Over the past week, KWR surged nearly 6% and NGVT climbed 7%. RPM gained just 1.2% over the same period. The sector is clearly in demand — RPM is simply not keeping pace, which frames the earnings event as a chance to explain the gap.

On the analyst side, Morgan Stanley lowered its Equal-Weight target to $114 from $117 on September 28 — a modest trim but the second consecutive cut from the same firm, reinforcing its cautious stance. The rest of the Street remains far more constructive. The mean target is $129.80, implying roughly 29% upside from current levels, and the analyst recommendation score ranks in the 94th percentile across the ORTEX universe. Bulls point to the company's $100 million cost-savings programme, diversified product mix across construction and industrial end-markets, and a forward earnings revision profile that ORTEX factor scores rank in the 89th percentile for year-on-year growth. Bears flag rising SG&A investment and margin pressure from construction sector uncertainty as the primary risks — and the stock's persistent underperformance relative to peers suggests the market isn't fully buying the growth story yet.

Short sellers are not a meaningful part of this setup. Short interest has fallen sharply — down 18% over the past week to just 2.5% of the free float — and borrow conditions are essentially frictionless, with availability vastly exceeding any plausible short demand. The short score has also eased from roughly 35 to 32.8 over the past two weeks. Positioning looks cautious through options rather than through short books, a distinction that matters: the hedging demand is concentrated near-term, not a structural bear thesis.

The October 2 print will test whether RPM's cost discipline and margin execution can close the credibility gap with a specialty chemicals peer group that has already re-rated higher.

Against its own history

This week's change in short interest is 1.7 standard deviations below the company's typical weekly move over the past year.

Against its peers

Shares moved +1.2% over the past week against a median of +2.7% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open RPM on ORTEX →

How this article was generated

Generated
29 Sept 2026, 04:02
Data as of
29 Sept 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.